LM
Lonestar Medicines, Inc.
SEC filingBiotechnology · Boston, MA
Amount raised$25Msold at filing
Total offering$45M$20M still open
Investors in the raise4count reported to the SEC
FiledFeb 23, 2026first sale Jan 12, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Naveen Manu DaryaniExecutive Officer
Andrew Manu LevinDirector
William Daley BonificioExecutive Officer, Promoter
Gianna Manu Hoffman-LucaDirector
Stephen Basil ThomasExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.